Vedolizumab is used in the treatment of ulcerative colitis, Crohn's disease, psoriasis, ankylosing spondylitis, and rheumatoid arthritis.
How Vedolizumab works: White blood cells (WBCs) are produced by the immune system to combat infection. In Ulcerative Colitis and Crohn’s Disease, the overproduction of WBCs results in inflammation. Vedolizumab functions by preventing WBCs from infiltrating the lining of the gut.
Common side effects of Vedolizumab include nasopharyngitis (inflammation of the throat and nasal passages), headache, nausea, joint pain, fever, upper respiratory tract infection, fatigue, cough, bronchitis (inflammation of the airways), influenza, back pain, rash, itching, sinus inflammation, oropharyngeal pain, and pain in the extremities.